Coming very soon, page-92

For me the important thing is this reusable AID and where that program is at?

Its feesible that they have a rather quick path to market and could easily be in parients hands next year ans fiving much needed earnings.

The only catch of course is they need a customer/s...either people/someone knows Abbvie is in the wings as otherwise i cant see any reason to be buying and an SP increase.

They again needed to bring forward funding by a qtr because they were about out of cash. Have hinted that they are holding thr IP and shelved platforms for now ao doesnt appear they can monetize unifill etc. And have stated they expect to be struggling with earnings through 2017 and into 2018. So i want to buy in but i cant make myself given this disclosed information.

Will certainly be paying attention on 2 Nov.